A prospective, controlled multisite trial of yoga in pediatric inflammatory bowel disease
Alycia Leiby, Lindsey Albenberg, Annette Langseder, Mary Kennedy, Naomi Pressman, Stephanie Chiu, Joel R. Rosh- Gastroenterology
- Pediatrics, Perinatology and Child Health
Abstract
Aim
To investigate whether a structured yoga program improves health‐related quality of life (HRQOL) and self‐efficacy in pediatric patients receiving care for inflammatory bowel disease (IBD).
Methods
IBD patients who were 10–17 years old participated in a 12 week, in‐person yoga intervention at two clinical sites. Outcomes were measured at time of consent (T0), start of yoga (T1), and completion of yoga (T2) and 3 months after yoga completion (T3) using the IMPACT‐III, Pediatric Quality of Life Inventory (PedsQL), and General Self Efficacy (GSE) scales.
Results
Seventy‐eight patients were enrolled. Fifty‐six patients completed nine or more classes. 73.2% had Crohn's disease and 26.8% ulcerative colitis or IBD‐unclassified. A significant increase in IMPACT‐III was seen from T1 to T3 (mean change of 5.22, SD = 14.33, p = 0.010), in the PedsQL (mean change = 2.3, SD = 10.24, p = 0.050), and GSE (mean change = 1, SD = 3.60, p = 0.046). 85.2% of patients reported yoga helped them to control stress. Long‐term data was available for 47 subjects with 31.9% (n = 15) continuing to practice yoga one to 3 years after study completion.
Conclusion
This structured 12‐week yoga program showed significant improvements in HRQOL and general self‐efficacy, particularly 3 months after classes were concluded suggesting that yoga's benefits may persist. Yoga is a safe and effective adjunct to standard medical care to improve QOL and self‐efficacy in youth with IBD.